HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulmonary veno-occlusive disease due to bleomycin therapy for lymphoma. Case reports.

Abstract
Two patients with lymphocytic lymphoma and bleomycin-induced pulmonary toxicity were shown at autopsy to have pulmonary venular alterations identical to pulmonary veno-occlusive disease (PVOD). While hepatic veno-occlusive disease due to alkylating agents has been reported, I am unaware of any report of PVOD related to bleomycin therapy.
AuthorsA G Rose
JournalSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde (S Afr Med J) Vol. 64 Issue 16 Pg. 636-8 (Oct 08 1983) ISSN: 0256-9574 [Print] South Africa
PMID6194564 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bleomycin
Topics
  • Adult
  • Bleomycin (adverse effects)
  • Constriction, Pathologic (chemically induced)
  • Humans
  • Lymphoma (drug therapy)
  • Male
  • Middle Aged
  • Pulmonary Veins (drug effects, pathology)
  • Thrombosis (chemically induced)
  • Venules (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: